Erratum: Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
Publication year - 2022
Publication title -
infection and chemotherapy
Language(s) - English
Resource type - Journals
eISSN - 2092-6448
pISSN - 1598-8112
DOI - 10.3947/ic.2022.0300
Subject(s) - medicine , fluvoxamine , covid-19 , randomized controlled trial , fluoxetine , disease , receptor , serotonin , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom